This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
How AI Can Help You Be More Resilient Against Tariffs In recent years, artificialIntelligence (AI) has been a game-changer for supply chain management, paving the way for more automation, enhanced decision-making, and optimization at every stage.
By adopting FAIR Data Principles, life sciences firms (pharmaceuticals, biotech, medical device manufacturers) can accelerate data sharing, improve data literacy (understanding of data) and increase overall transparency and auditability when working with data. How Collibra Data Intelligence Cloud can help.
Technology Disruption : How do we focus on innovation while leveraging existing technology, including artificialintelligence, machine learning, cloud and robotics? Emerging Markets : What opportunities align to our business (e.g., managing risk vs ROI and emerging countries)?
Along with cloud computing, artificialintelligence (AI), and robotic process automation (RPA), blockchain is transforming business operations and challenging traditional methods the world over. Manufacturers and consumers in global supply chains are calling for more transparency and traceability to combat these losses.
When thinking of artificialintelligence (AI) use cases, the question might be asked: What won’t AI be able to do? But right now, pure AI can be programmed for many tasks that require thought and intelligence , as long as that intelligence can be gathered digitally and used to train an AI system.
Now more than ever, we are also seeing financial institutions increasingly leverage HPC for capabilities like Monte Carlo simulations on market movements, including to power artificialintelligence (AI) and machine learning solutions that can be used to help enterprises make more informed decisions.
However, communication with managers can provide a good starting point, and many tools harness artificialintelligence (AI) and machine learning (ML) algorithms to improve visibility into typical activities. Also read: 10 Top Active Directory Security Tools. Critical Data Access.
For example, consider the hypothetical case of Class Action Plaintiffs vs. ABC Pharmaceutical Company. These mass anonymization and pseudonymization efforts may previously have been impractical or cost-prohibitive due to the sheer cost of anonymizing or pseudonymizing large volumes of documents.
So of course when I saw that some researchers were presenting a talk at SecTor 2021 in Toronto on defeating biometrics with artificialintelligence, well I knew I had to talk to them as well. The idea was to see whether a computer could possess a level of artificialintelligence that can mimic human responses under specific conditions.
With today’s new generative AI products, trust, security and regulatory issues remain top concerns for government healthcare officials and C-suite leaders representing biopharmaceutical companies, health systems, medical device manufacturers and other organizations.
On February 12, 2025, the Swiss Federal Council unveiled its long-awaited approach to artificialintelligence (AI) regulation. AI applications such as in drug development and manufacturing will need to align with these internationally recognized requirements. In MedTech, Switzerlands AI strategy presents a different challenge.
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content